Ventripoint Diagnostics' VMS+ Technology Selected for World-First AI Cardiac Monitoring Study in Breast Cancer Patients

Stock Information for EDAP TMS S.A.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About EDAP TMS S.A.

Ventripoint Issue Shares for Payment of Debenture Interest
Ventripoint Engages More Capital Ltd.
Ventripoint and Ollie Hinkle Heart Foundation Partner to Expand Access to AI-Powered Heart Imaging for Children Living with Heart Disease
16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap
Ventripoint Diagnostics Announces Support for the Global Congenital Heart Disease Alliance
Ventripoint Announces Adoption of Semi-Annual Reporting (SAR)
Ventripoint Provides Videoconference Link to Annual General Meeting and Corporate Update
Ventripoint Announces Closing of $308,030 Non-Brokered Units Private Placement

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.